Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Experimental & Molecular Medicine
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. experimental & molecular medicine
  3. articles
  4. article
Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 01 September 2001

Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers

  • Ki Sung Ryu1,
  • Youn Soo Lee,
  • Byung Kee Kim,
  • Yong Gyu Park,
  • Yong Wook Kim,
  • Soo Young Hur,
  • Tae Eung Kim,
  • In-Kyung Kim &
  • …
  • Jin Woo Kim 

Experimental & Molecular Medicine volume 33, pages 136–144 (2001)Cite this article

  • 886 Accesses

  • 21 Citations

  • Metrics details

Abstract

HLA expression is altered in a large variety of human cancers. We performed immunohistochemical staining on tissues from normal, preinvasive, invasive and metastatic cervical cancer tissues using anti-HLA class I or class II antibody. In tissues from normal squamous epithelium, carcinoma in situ (CIS) and microinvasive carcinoma (MIC), the expressions of HLA-B, C heavy chains and class II heavy chain were significantly decreased as disease progressed. When the expression patterns were compared between primary and metastatic squamous cell carcinoma (SCC) lesions, statistically significant down-regulation of HLA class I and class II antigen in metastatic lesions was observed. The rates of HLA-B, C heavy chains and class II heavy chain expressions were all significantly down-regulated compared to the down-regulation rate of class I β2-µglobulin (β2m) in invasive squamous lesions, and the expressions of class II heavy chain in metastatic lesions was decreased further than that in primary lesions. Unlike SCC, the degree of HLA class I and class II loss was not evident as disease progressed in early stage of adenocarcinoma. In invasive adenocarcinoma lesions, only the expression of HLA-B, C heavy chains was decreased and no differences were seen in HLA-B, C heavy chain expression patterns between primary and metastatic lesions. These results suggest that alterations of HLA class I and II expressions seem to occur at a particular step in cervical cancer development and depend on tissue types: when the tumor becomes invasive and starts to metastasize.

Similar content being viewed by others

Immunogenetic clustering of 30 cancers

Article Open access 04 May 2022

HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy

Article 20 January 2021

MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution

Article Open access 02 October 2024

Article PDF

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Kangnam St Mary's Hospital, Seoul

    Ki Sung Ryu

Authors
  1. Ki Sung Ryu
    View author publications

    Search author on:PubMed Google Scholar

  2. Youn Soo Lee
    View author publications

    Search author on:PubMed Google Scholar

  3. Byung Kee Kim
    View author publications

    Search author on:PubMed Google Scholar

  4. Yong Gyu Park
    View author publications

    Search author on:PubMed Google Scholar

  5. Yong Wook Kim
    View author publications

    Search author on:PubMed Google Scholar

  6. Soo Young Hur
    View author publications

    Search author on:PubMed Google Scholar

  7. Tae Eung Kim
    View author publications

    Search author on:PubMed Google Scholar

  8. In-Kyung Kim
    View author publications

    Search author on:PubMed Google Scholar

  9. Jin Woo Kim
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Ryu, K., Lee, Y., Kim, B. et al. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers. Exp Mol Med 33, 136–144 (2001). https://doi.org/10.1038/emm.2001.24

Download citation

  • Published: 01 September 2001

  • Issue date: 01 September 2001

  • DOI: https://doi.org/10.1038/emm.2001.24

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • cervical cancer
  • HLA class I
  • HLA class II
  • IHS
  • metastasis

This article is cited by

  • Differential expression of PD-L1 and IDO1 in association with the immune microenvironment in resected lung adenocarcinomas

    • M.Lisa Zhang
    • Marina Kem
    • Mari Mino-Kenudson

    Modern Pathology (2019)

  • Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases

    • Debbie M. Ferns
    • A. Marijne Heeren
    • Ekaterina S. Jordanova

    Journal for ImmunoTherapy of Cancer (2016)

  • A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens

    • Ursula J. E. Seidel
    • Claudia C. Oliveira
    • Thorbald van Hall

    Cancer Immunology, Immunotherapy (2012)

  • Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions

    • Naela A Arreygue-Garcia
    • Adrian Daneri-Navarro
    • Susana del Toro-Arreola

    BMC Cancer (2008)

  • EGFR mutation in various tissues

    • Kazuto Nishio
    • Tokuzo Arao
    • Hideyuki Yokote

    Cancer Chemotherapy and Pharmacology (2006)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Special Feature
  • Journal Information
  • About the Editors
  • About the Partner
  • Contact
  • For Advertisers
  • Press Releases
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Experimental & Molecular Medicine (Exp Mol Med)

ISSN 2092-6413 (online)

ISSN 1226-3613 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited